Meet ACELYRIN
Building a Different Kind of Biopharma Company
For Media and Investor Inquiries, contact:
Tyler Marciniak,
Vice President of Investor Relations,
Communications and Corporate Operations
Media Kit
Explore our site
Meet Our Leadership
We are led by experienced biopharma executives with exceptional track records of building strong, innovative and diverse teams across the healthcare industry.
Meet our leadership
See Our Pipeline
We are exploring innovative approaches in immunology where we have the opportunity to make a clinically meaningful difference for patients.
See our pipeline
ACELYRIN, INC. Announces Izokibep Achieves HiSCR100 Responses at 12 Weeks in Moderate-to-Severe Hidradenitis Suppurativa 
Press Release
ACELYRIN, INC. Announces Izokibep Achieves HiSCR100 Responses at 12 Weeks in Moderate-to-Severe Hidradenitis Suppurativa
Read more